Skip to content

Phonological Constraints on Language Development in Individuals With Williams Syndrome

Phonological Constraints on Language Development in Individuals With Williams Syndrome

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07285720
Acronym
SOUNDS
Enrollment
130
Registered
2025-12-16
Start date
2024-07-05
Completion date
2026-07-31
Last updated
2025-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

EEG-NIRS, Language, Phonological Short-Term Memory, Williams Syndrome

Keywords

Williams syndrome, Language, Phonological Short-Term Memory, EEG-NIRS

Brief summary

Williams syndrome (WS) is a neurodevelopmental disease characterized by mild to moderate intellectual disability and an extremely heterogeneous cognitive profile. Research has outlined two main features of WS: an atypical social behavior associated with surprising language abilities, and a hyperacusis. The purpose of this project is to investigate the relationships between both these abilities, and particularly the role of the hyperacusis on language abilities. The hyperacusis would be crucial in developing language skills: the apparent strength in the verbal domain could rely on Phonological Short Term Memory (PSTM) more in individuals with WS than in typically developing individuals. In addition, the investigators will compare individuals with WS to individuals with Down syndrome (DS): DS is often associated to strong limitations in the PSTM with poor language abilities. To this end, the investigators will use a highly innovative approach including physiological assessments (EEG-NIRS protocol) and questionnaires. The performance of people with WS will be compared to those of participants with DS and TD participants of same DA and cognitive assessments.

Interventions

OTHEREEG-NIRS protocol

Each participant will be tested individually in a quiet room at the GRAMFC (Groupe de Recherches sur l'Analyse Multimodale de la Fonction Cérébrale, INSERM-UMR1105, Université Picardie Jules Verne and CHU Amiens-Picardie). Duration of subject's participation in the study is 120 minutes

OTHERQuestionnaire

Each participant will be tested individually in a quiet room at the GRAMFC (Groupe de Recherches sur l'Analyse Multimodale de la Fonction Cérébrale, INSERM-UMR1105, Université Picardie Jules Verne and CHU Amiens-Picardie). Duration of subject's participation in the study is 120 minutes

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* For SW and SD: genetic diagnosis and aged between 6- and 17 years old. * For typical participants: any child, adolescent or young adult of the same developmental or chronological age (between 6 and 17 years of age) * adult group (between 20 and 60 years).

Exclusion criteria

* Autistic Associated Disorders, * West syndrome

Design outcomes

Primary

MeasureTime frameDescription
questionnaire score of patients with WS caracterisation2 yearsquestionnaire score for cognitive profile of patients with WS caracterisation

Secondary

MeasureTime frameDescription
Impact of hyperacusis on questionnaire score2 yearsImpact of hyperacusis on questionnaire score

Countries

France

Contacts

Primary ContactFabrice Wallois, Pr
fabrice.wallois@u-picardie.fr33+3 22 08 77 75

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026